Hospital pharmacy specialisation

Hospital pharmacy specialisation advances patient safety and the achievement of high quality healthcare.

Read more about EAHP's campaign to enable the recognition and harmonisation of hospital pharmacy specialisation here.

Bar coding medicines to the single unit 

A complete identification of a medicine, up to the moment of administration, is a key element of a safe medicines dispensing procedure in hospitals.

Read more about EAHP’s activity to realise the objective of bar coding medicines to the single unit administered in hospitals here.

Improving clinical trial regulation

There are many ways in which clinical trials regulation in Europe could be improved.

EAHP have set out some of these in a recent statement, including calling for:

• a single european electronic portal for submitting trials for assessment;
• a process for multi-sponsor trials; and,
• more open access to clinical trial data, 

Find out more here.

Resolving problems in hospitals caused by medicines shortages

Problems caused by medicines shortages are serious, threaten patient care in hospitals and require urgent action.

EAHP's statement on shortages outlines the nature of the problem and the activity required by each part of the supply chain to resolve the problem.

It also calls for a European-wide investigation involving the European Commission, European Medicines Agency and European Heads of Medicines Agencies.

Find out more here.

Other policy issues

EAHP also makes frequent representations at a European level on a range of important matters including in relation to:

• forthcoming legislation,
• current and emerging issues, and
• partnership working with other stakeholders. 

You can read more about this here.

Get involved and keep up to date

If you are a hospital pharmacist, a patient or patient representative, and wish to be more involved in our advocacy activity click here.

If you would like to sign up to receive weekly emails on EU matters relevant to hospital pharmacy click here.

See also the EU Monitor section of our website for more information here.

You can also follow us on Facebook, Twitter, and LinkedIn.